Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation
dc.contributor.author | Meade, Julie | |
dc.contributor.author | Gül, Zülfiye | |
dc.contributor.author | Bağdaş, Deniz | |
dc.contributor.buuauthor | Cam, Betül | |
dc.contributor.buuauthor | Cinkılıç, Nilüfer | |
dc.contributor.buuauthor | Gürün, Mine Sibel | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Bursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3595-6286 | tr_TR |
dc.contributor.researcherid | AAH-5296-2021 | tr_TR |
dc.contributor.researcherid | CGO-3719-2022 | tr_TR |
dc.contributor.researcherid | DVX-8040-2022 | tr_TR |
dc.contributor.scopusid | 56427863700 | tr_TR |
dc.contributor.scopusid | 26533892300 | tr_TR |
dc.contributor.scopusid | 55664349700 | tr_TR |
dc.date.accessioned | 2022-12-19T12:11:21Z | |
dc.date.available | 2022-12-19T12:11:21Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Background: Natural phenolic compounds in medicinal herbs and dietary plants are antioxidants which play therapeutic or preventive roles in different pathological situations, such as oxidative stress and inflammation. One of the most studied phenolic compounds in the last decade is chlorogenic acid (CGA), which is a potent antioxidant found in certain foods and drinks. Objective: This review focuses on the anti-inflammatory and antinociceptive bioactivities of CGA, and the putative mechanisms of action are described. Ethnopharmacological reports related to these bioactivities are also reviewed. Materials and Methods: An electronic literature search was conducted by authors up to October 2019. Original articles were selected. Results: CGA has been shown to reduce inflammation and modulate inflammatory and neuropathic pain in animal models. Conclusion: The consensus of the literature search was that systemic CGA may facilitate pain management via bolstering antioxidant defenses against inflammatory insults. | en_US |
dc.identifier.citation | Bağdaş, D. vd. (2020). "Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation". Current Neuropharmacology, 18(3), 216-228. | en_US |
dc.identifier.endpage | 228 | tr_TR |
dc.identifier.issn | 1570-159X | |
dc.identifier.issn | 1875-6190 | |
dc.identifier.issue | 3 | tr_TR |
dc.identifier.pubmed | 31631820 | tr_TR |
dc.identifier.scopus | 2-s2.0-85079435812 | tr_TR |
dc.identifier.startpage | 216 | tr_TR |
dc.identifier.uri | https://doi.org/10.2174/1570159X17666191021111809 | |
dc.identifier.uri | http://www.eurekaselect.com/article/101699 | |
dc.identifier.uri | http://hdl.handle.net/11452/29959 | |
dc.identifier.volume | 18 | tr_TR |
dc.identifier.wos | 000514651000004 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science | en_US |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.journal | Current Neuropharmacology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Chlorogenic | en_US |
dc.subject | Acid | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Pain | en_US |
dc.subject | Inflammatory | en_US |
dc.subject | Neuropathic | en_US |
dc.subject | Antihyperalgesic | en_US |
dc.subject | Antiallodynic | en_US |
dc.subject | NF-Kappa B | en_US |
dc.subject | Gated potassium channels | en_US |
dc.subject | Gaba receptor agonists | en_US |
dc.subject | Nitric-oxide synthase | en_US |
dc.subject | Incuded liver-injury | tr_TR |
dc.subject | Oxygen species ros | en_US |
dc.subject | Hypericum-perforatum | en_US |
dc.subject | Caffeic acid | en_US |
dc.subject | Neuropathic pain | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject.emtree | Antioxidant | en_US |
dc.subject.emtree | Bidens pilosa extract | en_US |
dc.subject.emtree | Caffeic acid | tr_TR |
dc.subject.emtree | Cheilanthes farinose extract | en_US |
dc.subject.emtree | Chlorogenic acid | en_US |
dc.subject.emtree | Chlorogenic acid derivative | en_US |
dc.subject.emtree | Cnidium officinale extract | en_US |
dc.subject.emtree | Drug metabolite | en_US |
dc.subject.emtree | Erycibe obtusifolia extract | en_US |
dc.subject.emtree | Ferulic acid | en_US |
dc.subject.emtree | Hypericum perforatum extract | en_US |
dc.subject.emtree | Ion channel | en_US |
dc.subject.emtree | Mansoa alliacea extract | en_US |
dc.subject.emtree | Plant extract | en_US |
dc.subject.emtree | Porana sinensis extract | en_US |
dc.subject.emtree | Rosae multiflorae extract | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Urtica circularis extract | en_US |
dc.subject.emtree | Analgesic agent | en_US |
dc.subject.emtree | Antiinflammatory agent | en_US |
dc.subject.emtree | Chlorogenic acid | en_US |
dc.subject.emtree | Plant extract | en_US |
dc.subject.emtree | Antiinflammatory activity | en_US |
dc.subject.emtree | Antinociception | en_US |
dc.subject.emtree | Arthritis | en_US |
dc.subject.emtree | Chronic pain | en_US |
dc.subject.emtree | Consensus | en_US |
dc.subject.emtree | Degenerative disease | en_US |
dc.subject.emtree | Disease model | en_US |
dc.subject.emtree | Drug mechanism | en_US |
dc.subject.emtree | Ethnopharmacology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | In vivo study | en_US |
dc.subject.emtree | Inflammation | en_US |
dc.subject.emtree | Inflammatory pain | en_US |
dc.subject.emtree | Neuropathic pain | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pain | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Rheumatoid arthritis | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Chronic pain | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Encephalitis | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Sepsis | en_US |
dc.subject.mesh | Analgesics | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-inflammatory agents | en_US |
dc.subject.mesh | Chlorogenic acid | en_US |
dc.subject.mesh | Chronic pain | en_US |
dc.subject.mesh | Disease models | en_US |
dc.subject.mesh | Animal | en_US |
dc.subject.mesh | Encephalitis | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Plant extracts | en_US |
dc.subject.mesh | Sepsis | en_US |
dc.subject.scopus | Antioxidant; Carlina Oxide; Lonicera | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.title | Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation | en_US |
dc.type | Article | |
dc.wos.quartile | Q1 | en_US |